Literature DB >> 1500753

Comparison of urine and serum concentrations of interleukin-6 in women with acute pyelonephritis or asymptomatic bacteriuria.

S Hedges1, K Stenqvist, G Lidin-Janson, J Martinell, T Sandberg, C Svanborg.   

Abstract

The mucosal and systemic interleukin-6 (IL-6) response to urinary tract infection was analyzed in women with acute pyelonephritis or asymptomatic bacteriuria. Urine and serum samples were obtained at diagnosis and after treatment. IL-6 activity was elevated in urine samples from most bacteriuric women, regardless of the severity of infection. Urinary levels greater than 20 units/mL occurred in 25 of 29 women with acute pyelonephritis and in 36 of 42 women with asymptomatic bacteriuria. Elevated serum IL-6 levels were found mainly in patients with acute pyelonephritis: Levels greater than 20 units/mL occurred in 14 of 28 women with acute pyelonephritis compared with 0 of 28 women with asymptomatic bacteriuria. These results suggest that bacteriuria is accompanied by elevated urinary IL-6 levels and that this IL-6 is locally produced. The spread of IL-6 to the circulation in patients with acute pyelonephritis may contribute to the elevation of fever and C-reactive protein characteristic of the disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500753     DOI: 10.1093/infdis/166.3.653

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

1.  Pharmacologic Basis for the Treatment of Pyelonephritis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

2.  Sequential measurements of chemokines in urosepsis and experimental endotoxemia.

Authors:  D P Olszyna; J M Prins; P E Dekkers; E De Jonge; P Speelman; S J Van Deventer; T Van Der Poll
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

3.  Global gene expression profiling of renal scarring in a rat model of pyelonephritis.

Authors:  Manabu Ichino; Terumi Mori; Mamoru Kusaka; Yoko Kuroyanagi; Kiyohito Ishikawa; Ryoichi Shiroki; Hiroe Kowa; Hiroki Kurahashi; Kiyotaka Hoshinaga
Journal:  Pediatr Nephrol       Date:  2008-01-23       Impact factor: 3.714

4.  Autocrine effects of interleukin-6 mediate acute-phase proinflammatory and tissue-reparative transcriptional responses of canine bladder mucosa.

Authors:  Michael W Wood; Edward B Breitschwerdt; Jody L Gookin
Journal:  Infect Immun       Date:  2010-11-29       Impact factor: 3.441

5.  Interleukin-8 and the neutrophil response to mucosal gram-negative infection.

Authors:  W W Agace; S R Hedges; M Ceska; C Svanborg
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

6.  Evaluation of inflammatory and renal-injury markers in women treated with antibiotics for acute pyelonephritis caused by Escherichia coli.

Authors:  Juan P Horcajada; María Velasco; Xavier Filella; Luisa Alvarez; Elisa De Làzzari; Jose Luis Marín; Blanca Collvinent; Alex Smithson; Jose Antonio Martínez; Mariana Noguero; Jordi Vila; Josep Mensa
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

7.  Interleukin-6 and interleukin-8 in the urine of children with acute pyelonephritis.

Authors:  K Tullus; O Fituri; L G Burman; B Wretlind; A Brauner
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

8.  Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa.

Authors:  Patrik Samuelsson; Long Hang; Björn Wullt; Heikki Irjala; Catharina Svanborg
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

Review 9.  Bladder, bowel and bugs--bacteriuria in patients with intestinal urinary diversion.

Authors:  Björn Wullt; William Agace; Wiking Mansson
Journal:  World J Urol       Date:  2004-08-07       Impact factor: 4.226

10.  Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in women.

Authors:  Thomas R Hawn; Delia Scholes; Hongwei Wang; Sue S Li; Ann E Stapleton; Marta Janer; Alan Aderem; Walter E Stamm; Lue Ping Zhao; Thomas M Hooton
Journal:  PLoS One       Date:  2009-12-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.